{"product_id":"tirzepatide-weight-loss-san-antonio","title":"Tirzepatide Weight Loss in San Antonio | From $250 | DaVida","description":"\u003c!-- =============================================================\n     DAVIDA — TIRZEPATIDE WEIGHT LOSS\n     Custom product description (paste into Shopify source view)\n     ============================================================\n     INSTALL:\n     1. Shopify admin → Products → Tirzepatide Weight Loss Program\n     2. In the Description editor, click the \"\u003c\u003e\" (source code) icon\n     3. Delete any existing description content\n     4. Paste this entire file (everything between the comment blocks)\n     5. Save\n\n     SEO TARGETS:\n     Primary:           tirzepatide san antonio\n     Secondary:         weight loss san antonio, tirzepatide cost, mounjaro alternative, dual glp-1 gip\n     Long-tail:         tirzepatide vs semaglutide, tirzepatide low dose vs high dose, tirzepatide weight loss san antonio, tirzepatide starter pack cost\n     ============================================================= --\u003e\n\u003cstyle\u003e\n.dvd-pd { font-family: 'Inter', -apple-system, sans-serif; color: #2A2A2A; line-height: 1.7; }\n.dvd-pd * { box-sizing: border-box; }\n.dvd-pd__hero {\n  background: linear-gradient(135deg, #FAFAF7 0%, #F8F4ED 100%);\n  border: 1px solid #EDE5D9; border-radius: 12px; padding: 32px 28px;\n  margin: 0 0 32px; text-align: center;\n}\n.dvd-pd__eyebrow {\n  font-size: 0.7rem; font-weight: 600; letter-spacing: 0.18em; text-transform: uppercase;\n  color: #B68543; margin: 0 0 8px;\n}\n.dvd-pd__hero-heading {\n  font-family: 'Playfair Display', Georgia, serif; font-weight: 500; font-size: 1.65rem;\n  letter-spacing: -0.005em; color: #1A1A1A; margin: 0 0 12px; line-height: 1.25;\n}\n.dvd-pd__hero-text {\n  font-size: 0.98rem; color: #5c5246; margin: 0;\n  max-width: 540px; margin-left: auto; margin-right: auto;\n}\n.dvd-pd__section { margin: 40px 0; }\n.dvd-pd__section-heading {\n  font-family: 'Playfair Display', Georgia, serif; font-weight: 500; font-size: 1.4rem;\n  color: #1A1A1A; margin: 0 0 16px; letter-spacing: -0.005em;\n}\n.dvd-pd__benefits {\n  display: grid; grid-template-columns: repeat(2, 1fr); gap: 12px;\n}\n.dvd-pd__benefit-item {\n  background: #FFFFFF; border: 1px solid #EDE5D9; border-radius: 8px; padding: 16px;\n}\n.dvd-pd__benefit-name {\n  font-family: 'Playfair Display', Georgia, serif; font-weight: 500; font-size: 1rem;\n  color: #1A1A1A; margin: 0 0 4px; display: block;\n}\n.dvd-pd__benefit-desc {\n  font-size: 0.86rem; color: #5c5246; line-height: 1.5; margin: 0;\n}\n.dvd-pd__concerns { display: flex; flex-wrap: wrap; gap: 8px; }\n.dvd-pd__concern-pill {\n  display: inline-block; padding: 8px 16px; background: #FFFFFF;\n  border: 1px solid #E5DDD3; border-radius: 999px; font-size: 0.82rem;\n  font-weight: 500; color: #2c2219; letter-spacing: 0.02em;\n}\n.dvd-pd__ingredients { display: grid; gap: 14px; }\n.dvd-pd__ingredient {\n  background: #FAFAF7; border-left: 3px solid #B68543; border-radius: 4px; padding: 16px 18px;\n}\n.dvd-pd__ingredient-name {\n  font-family: 'Inter', sans-serif; font-size: 0.95rem; font-weight: 700;\n  color: #B68543; letter-spacing: 0.02em; margin: 0 0 4px; display: block;\n}\n.dvd-pd__ingredient-desc {\n  font-size: 0.92rem; color: #2c2219; margin: 0; line-height: 1.55;\n}\n.dvd-pd__routine { display: grid; grid-template-columns: repeat(2, 1fr); gap: 16px; }\n.dvd-pd__routine-col {\n  background: #FFFFFF; border: 1px solid #EDE5D9; border-radius: 8px; padding: 20px;\n}\n.dvd-pd__routine-col-heading {\n  font-family: 'Inter', sans-serif; font-size: 0.7rem; font-weight: 700;\n  letter-spacing: 0.18em; text-transform: uppercase; color: #B68543; margin: 0 0 12px;\n}\n.dvd-pd__routine-list { list-style: none; padding: 0; margin: 0; counter-reset: step; }\n.dvd-pd__routine-list li {\n  counter-increment: step; position: relative; padding: 0 0 12px 32px;\n  font-size: 0.9rem; color: #2c2219; line-height: 1.55;\n}\n.dvd-pd__routine-list li:last-child { padding-bottom: 0; }\n.dvd-pd__routine-list li::before {\n  content: counter(step); position: absolute; left: 0; top: 0;\n  width: 22px; height: 22px; border-radius: 50%; background: #1A1A1A; color: #FFFFFF;\n  font-size: 0.72rem; font-weight: 600; display: flex; align-items: center;\n  justify-content: center; font-family: 'Inter', sans-serif;\n}\n.dvd-pd__faq { margin-top: 8px; }\n.dvd-pd__faq-item { border-bottom: 1px solid #EDE5D9; padding: 0; }\n.dvd-pd__faq-item summary {\n  cursor: pointer; padding: 16px 0; font-family: 'Inter', sans-serif;\n  font-weight: 600; font-size: 0.95rem; color: #1A1A1A;\n  list-style: none; position: relative; padding-right: 32px;\n}\n.dvd-pd__faq-item summary::-webkit-details-marker { display: none; }\n.dvd-pd__faq-item summary::after {\n  content: \"+\"; position: absolute; right: 4px; top: 50%; transform: translateY(-50%);\n  font-size: 1.3rem; color: #B68543; font-weight: 400; transition: transform 0.2s ease;\n}\n.dvd-pd__faq-item[open] summary::after { content: \"−\"; }\n.dvd-pd__faq-answer {\n  padding: 0 0 16px; font-size: 0.92rem; color: #5c5246; line-height: 1.65;\n}\n.dvd-pd__faq-answer p { margin: 0 0 8px; }\n.dvd-pd__faq-answer p:last-child { margin: 0; }\n.dvd-pd__closer {\n  background: #1A1A1A; color: #FFFFFF; border-radius: 12px;\n  padding: 28px; text-align: center; margin: 40px 0 0;\n}\n.dvd-pd__closer-eyebrow {\n  font-size: 0.7rem; font-weight: 600; letter-spacing: 0.18em;\n  text-transform: uppercase; color: #B68543; margin: 0 0 10px;\n}\n.dvd-pd__closer-text {\n  font-family: 'Playfair Display', Georgia, serif; font-style: italic;\n  font-weight: 400; font-size: 1.05rem; line-height: 1.55; margin: 0 0 8px; color: #FFFFFF;\n}\n.dvd-pd__closer-attr {\n  font-family: 'Inter', sans-serif; font-size: 0.78rem;\n  color: rgba(255,255,255,0.7); letter-spacing: 0.04em;\n}\n@media (max-width: 600px) {\n  .dvd-pd__benefits, .dvd-pd__routine { grid-template-columns: 1fr; }\n  .dvd-pd__hero { padding: 24px 20px; }\n  .dvd-pd__hero-heading { font-size: 1.4rem; }\n  .dvd-pd__section-heading { font-size: 1.2rem; }\n}\n\u003c\/style\u003e\n\u003cdiv class=\"dvd-pd\"\u003e\n  \u003cdiv class=\"dvd-pd__hero\"\u003e\n    \u003cdiv class=\"dvd-pd__eyebrow\"\u003eMedical Weight Loss · From $250\u003c\/div\u003e\n    \u003ch2 class=\"dvd-pd__hero-heading\"\u003eTirzepatide weight loss — the dual-action medication producing the most dramatic results.\u003c\/h2\u003e\n    \u003cp class=\"dvd-pd__hero-text\"\u003eTirzepatide is a dual GLP-1 + GIP receptor agonist — the newest and most-effective FDA-approved weight loss medication on the market. The dual mechanism produces greater average weight loss than semaglutide in clinical trials, with similar tolerability. At DaVida Medical Aesthetics in San Antonio, our tirzepatide program is medically supervised, with low-dose and high-dose options to fit your goals and budget across 3-month and 6-month durations.\u003c\/p\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"dvd-pd__section\"\u003e\n    \u003ch3 class=\"dvd-pd__section-heading\"\u003eWhy people reach for it\u003c\/h3\u003e\n    \u003cdiv class=\"dvd-pd__benefits\"\u003e\n      \u003cdiv class=\"dvd-pd__benefit-item\"\u003e\n        \u003cspan class=\"dvd-pd__benefit-name\"\u003eDual GLP-1 + GIP mechanism\u003c\/span\u003e\n        \u003cp class=\"dvd-pd__benefit-desc\"\u003eTirzepatide is the first dual GLP-1 + GIP receptor agonist — meaning it activates two complementary metabolic pathways simultaneously, producing more weight loss than single-pathway medications in clinical trials.\u003c\/p\u003e\n      \u003c\/div\u003e\n      \u003cdiv class=\"dvd-pd__benefit-item\"\u003e\n        \u003cspan class=\"dvd-pd__benefit-name\"\u003eGreater average weight loss\u003c\/span\u003e\n        \u003cp class=\"dvd-pd__benefit-desc\"\u003eClinical trials show tirzepatide producing 15–20% body weight loss for most patients at the highest doses — measurably greater than semaglutide's 12–15% average. The dual mechanism is the difference.\u003c\/p\u003e\n      \u003c\/div\u003e\n      \u003cdiv class=\"dvd-pd__benefit-item\"\u003e\n        \u003cspan class=\"dvd-pd__benefit-name\"\u003eLow-dose and high-dose options\u003c\/span\u003e\n        \u003cp class=\"dvd-pd__benefit-desc\"\u003eOur pricing offers both low-dose (2.5–7.5mg) and high-dose (10–15mg) tiers — letting clients start lower and titrate up, or commit to high-dose for maximum results from the start.\u003c\/p\u003e\n      \u003c\/div\u003e\n      \u003cdiv class=\"dvd-pd__benefit-item\"\u003e\n        \u003cspan class=\"dvd-pd__benefit-name\"\u003eMedically supervised\u003c\/span\u003e\n        \u003cp class=\"dvd-pd__benefit-desc\"\u003eEvery tirzepatide program is supervised by a licensed provider — eligibility screening, dose titration, side-effect management, and ongoing monitoring throughout your treatment course.\u003c\/p\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"dvd-pd__section\"\u003e\n    \u003ch3 class=\"dvd-pd__section-heading\"\u003eWho it's for\u003c\/h3\u003e\n    \u003cp style=\"margin: 0 0 14px; color: #5c5246; font-size: 0.95rem;\"\u003eTirzepatide may be right for clients dealing with:\u003c\/p\u003e\n    \u003cdiv class=\"dvd-pd__concerns\"\u003e\n      \u003cspan class=\"dvd-pd__concern-pill\"\u003eSignificant excess weight\u003c\/span\u003e\n      \u003cspan class=\"dvd-pd__concern-pill\"\u003eStalled weight loss\u003c\/span\u003e\n      \u003cspan class=\"dvd-pd__concern-pill\"\u003eType 2 diabetes (with provider guidance)\u003c\/span\u003e\n      \u003cspan class=\"dvd-pd__concern-pill\"\u003eInsulin resistance\u003c\/span\u003e\n      \u003cspan class=\"dvd-pd__concern-pill\"\u003eMetabolic syndrome\u003c\/span\u003e\n      \u003cspan class=\"dvd-pd__concern-pill\"\u003eFailed previous weight-loss attempts\u003c\/span\u003e\n      \u003cspan class=\"dvd-pd__concern-pill\"\u003eGreater results than semaglutide\u003c\/span\u003e\n      \u003cspan class=\"dvd-pd__concern-pill\"\u003eBody recomposition goals\u003c\/span\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"dvd-pd__section\"\u003e\n    \u003ch3 class=\"dvd-pd__section-heading\"\u003eWhy it works\u003c\/h3\u003e\n    \u003cdiv class=\"dvd-pd__ingredients\"\u003e\n      \u003cdiv class=\"dvd-pd__ingredient\"\u003e\n        \u003cspan class=\"dvd-pd__ingredient-name\"\u003eDual receptor agonism\u003c\/span\u003e\n        \u003cp class=\"dvd-pd__ingredient-desc\"\u003eTirzepatide activates both GLP-1 and GIP receptors — two complementary metabolic pathways. The dual action produces stronger appetite suppression and more significant weight loss than single-receptor medications.\u003c\/p\u003e\n      \u003c\/div\u003e\n      \u003cdiv class=\"dvd-pd__ingredient\"\u003e\n        \u003cspan class=\"dvd-pd__ingredient-name\"\u003eGLP-1 component\u003c\/span\u003e\n        \u003cp class=\"dvd-pd__ingredient-desc\"\u003eThe GLP-1 portion mimics the body's natural appetite-regulating hormone — slowing gastric emptying, signaling fullness, and reducing food cravings between meals.\u003c\/p\u003e\n      \u003c\/div\u003e\n      \u003cdiv class=\"dvd-pd__ingredient\"\u003e\n        \u003cspan class=\"dvd-pd__ingredient-name\"\u003eGIP component\u003c\/span\u003e\n        \u003cp class=\"dvd-pd__ingredient-desc\"\u003eThe GIP component provides the additional metabolic action — improving insulin response, reducing fat storage signals, and supporting the dual-pathway weight loss benefit unique to tirzepatide.\u003c\/p\u003e\n      \u003c\/div\u003e\n      \u003cdiv class=\"dvd-pd__ingredient\"\u003e\n        \u003cspan class=\"dvd-pd__ingredient-name\"\u003eProvider-calibrated dosing\u003c\/span\u003e\n        \u003cp class=\"dvd-pd__ingredient-desc\"\u003eDoses titrate from low (2.5–7.5mg) to high (10–15mg) based on your response, tolerance, and goals. Your provider adjusts throughout the program to optimize results while managing side effects.\u003c\/p\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"dvd-pd__section\"\u003e\n    \u003ch3 class=\"dvd-pd__section-heading\"\u003eWhat to expect\u003c\/h3\u003e\n    \u003cdiv class=\"dvd-pd__routine\"\u003e\n      \u003cdiv class=\"dvd-pd__routine-col\"\u003e\n        \u003cdiv class=\"dvd-pd__routine-col-heading\"\u003eStarting the Program\u003c\/div\u003e\n        \u003col class=\"dvd-pd__routine-list\"\u003e\n          \u003cli\u003eInitial consultation: medical history, eligibility screening, goal-setting\u003c\/li\u003e\n          \u003cli\u003eProvider determines starting dose tier (low or high)\u003c\/li\u003e\n          \u003cli\u003eBloodwork if needed; prescription and injection training provided\u003c\/li\u003e\n          \u003cli\u003eBegin weekly self-administered injections\u003c\/li\u003e\n        \u003c\/ol\u003e\n      \u003c\/div\u003e\n      \u003cdiv class=\"dvd-pd__routine-col\"\u003e\n        \u003cdiv class=\"dvd-pd__routine-col-heading\"\u003eThrough Your Program\u003c\/div\u003e\n        \u003col class=\"dvd-pd__routine-list\"\u003e\n          \u003cli\u003eWeeks 1–4: Starting dose; body adjusts; tolerance assessed\u003c\/li\u003e\n          \u003cli\u003eWeeks 4–12: Dose titration up if appropriate; significant weight loss begins\u003c\/li\u003e\n          \u003cli\u003eMonths 3–6: Sustained progress; many clients see 15–20% body weight reduction at higher doses\u003c\/li\u003e\n          \u003cli\u003eMaintenance: continue, transition off, or move to lower-dose maintenance based on goals\u003c\/li\u003e\n        \u003c\/ol\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"dvd-pd__section\"\u003e\n    \u003ch3 class=\"dvd-pd__section-heading\"\u003eCommon questions\u003c\/h3\u003e\n    \u003cdiv class=\"dvd-pd__faq\"\u003e\n      \u003cdetails class=\"dvd-pd__faq-item\"\u003e\n        \u003csummary\u003eHow much does Tirzepatide cost at DaVida?\u003c\/summary\u003e\n        \u003cdiv class=\"dvd-pd__faq-answer\"\u003e\n          \u003cp\u003ePricing depends on dose tier and duration. Starter pack: $250. 3-month: low dose (2.5–7.5mg) $849, high dose (10–15mg) $1,299. 6-month: low dose $1,650, high dose $2,550. Longer commitments and higher doses are priced for clients ready to commit to maximum results — the 6-month high-dose option produces the most dramatic outcomes.\u003c\/p\u003e\n        \u003c\/div\u003e\n      \u003c\/details\u003e\n      \u003cdetails class=\"dvd-pd__faq-item\"\u003e\n        \u003csummary\u003eWhat's the difference between low dose and high dose?\u003c\/summary\u003e\n        \u003cdiv class=\"dvd-pd__faq-answer\"\u003e\n          \u003cp\u003eLow dose (2.5–7.5mg) is appropriate for clients starting tirzepatide, those with lower weight loss goals, or anyone wanting to confirm tolerance before committing to higher doses. High dose (10–15mg) produces the maximum weight loss documented in clinical trials but requires most patients to titrate up from a lower starting dose. Your provider determines appropriate starting and target doses.\u003c\/p\u003e\n        \u003c\/div\u003e\n      \u003c\/details\u003e\n      \u003cdetails class=\"dvd-pd__faq-item\"\u003e\n        \u003csummary\u003eTirzepatide vs Semaglutide — which is better?\u003c\/summary\u003e\n        \u003cdiv class=\"dvd-pd__faq-answer\"\u003e\n          \u003cp\u003eBoth are excellent GLP-1 medications. Tirzepatide's dual GLP-1 + GIP mechanism produces somewhat greater weight loss on average — clinical trials show 15–20% vs semaglutide's 12–15%. Tirzepatide is also slightly newer with less long-term data. Semaglutide has the longer track record. The right choice depends on your goals, medical history, and how aggressive you want to be with your weight loss.\u003c\/p\u003e\n        \u003c\/div\u003e\n      \u003c\/details\u003e\n      \u003cdetails class=\"dvd-pd__faq-item\"\u003e\n        \u003csummary\u003eWhat are the common side effects?\u003c\/summary\u003e\n        \u003cdiv class=\"dvd-pd__faq-answer\"\u003e\n          \u003cp\u003eTirzepatide has a similar side-effect profile to semaglutide — primarily gastrointestinal (nausea, mild stomach upset, occasional constipation or diarrhea) particularly in early weeks or after dose increases. Most side effects resolve as your body adjusts. Serious side effects are rare but discussed during eligibility screening.\u003c\/p\u003e\n        \u003c\/div\u003e\n      \u003c\/details\u003e\n      \u003cdetails class=\"dvd-pd__faq-item\"\u003e\n        \u003csummary\u003eHow quickly will I see results?\u003c\/summary\u003e\n        \u003cdiv class=\"dvd-pd__faq-answer\"\u003e\n          \u003cp\u003eInitial weight loss typically begins within the first 4–8 weeks. Significant weight loss (10%+ of body weight) commonly occurs by months 3–6, particularly at higher doses. Maximum results from a full 6-month or 1-year program — clinical trials documented continued weight loss through 72 weeks of treatment at the highest dose.\u003c\/p\u003e\n        \u003c\/div\u003e\n      \u003c\/details\u003e\n      \u003cdetails class=\"dvd-pd__faq-item\"\u003e\n        \u003csummary\u003eWho isn't a candidate for tirzepatide?\u003c\/summary\u003e\n        \u003cdiv class=\"dvd-pd__faq-answer\"\u003e\n          \u003cp\u003eTirzepatide isn't appropriate for clients with personal\/family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastroparesis, or pregnancy\/breastfeeding. Eligibility is screened during your initial consultation by our supervising provider.\u003c\/p\u003e\n        \u003c\/div\u003e\n      \u003c\/details\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"dvd-pd__closer\"\u003e\n    \u003cdiv class=\"dvd-pd__closer-eyebrow\"\u003eWhy our team loves it\u003c\/div\u003e\n    \u003cp class=\"dvd-pd__closer-text\"\u003e\"Tirzepatide is the medication producing the most dramatic results in modern weight-loss medicine — the dual mechanism is genuinely unique and the clinical results back the price difference. Our medical supervision and tiered dosing structure make it accessible for clients ready to invest in significant transformation. Longer commitments + higher doses = the most life-changing outcomes we see at our practice.\"\u003c\/p\u003e\n    \u003cdiv class=\"dvd-pd__closer-attr\"\u003e— The DaVida Aesthetics Team\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!-- END TIRZEPATIDE WEIGHT LOSS description --\u003e","brand":"DaVida Skin","offers":[{"title":"Starter","offer_id":44302774140970,"sku":null,"price":250.0,"currency_code":"USD","in_stock":true},{"title":"3-Month Low Dose","offer_id":44302774173738,"sku":null,"price":849.0,"currency_code":"USD","in_stock":true},{"title":"3-Month High Dose","offer_id":44302774206506,"sku":null,"price":1299.0,"currency_code":"USD","in_stock":true},{"title":"6-Month Low Dose","offer_id":44302774239274,"sku":null,"price":1650.0,"currency_code":"USD","in_stock":true},{"title":"6-Month High Dose","offer_id":44302774272042,"sku":null,"price":2550.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0593\/4301\/1882\/files\/384.png?v=1777586898","url":"https:\/\/davidaskin.com\/products\/tirzepatide-weight-loss-san-antonio","provider":"DaVida Skin","version":"1.0","type":"link"}